Launch Date
05/14/2025 at 07:30 pm EST
Credit Amount
Credit Expires
05/14/2025
Acromegaly presents a diagnostic and management challenge due to its gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to prolonged morbidity and increased mortality. However, emerging therapies, including novel oral options, offer new opportunities for personalized treatment strategies that align with patient preferences, adherence challenges, and comorbidities.
In this CME Outfitters livestream symposium, leading experts will explore:
✅ Early, guideline-based diagnosis to improve patient outcomes
✅ The latest efficacy and safety data on current and emerging therapies, including oral treatments
✅ Individualized care strategies that consider patient needs, comorbidities, and barriers to adherence
Stay ahead of the curve with cutting-edge insights to enhance patient care and optimize long-term management of acromegaly.
At the conclusion of this activity, learners will be able to better:
This program is supported by an educational grant from Crinetics Pharmaceuticals.
Endocrinologists, physician associates (PAs), nurse practitioners (NPs), nurses, and other HCPs who manage patients with acromegaly
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
The following individuals have no financial relationships to disclose:
Thai Nguyen, MD, MHA (Peer Reviewer)
Jessica Giddens, DNP, APRN, FPMHNP-BC, RN-BC (Peer Reviewer)
Susan Perry (Planning Committee)
Felicia Oyedepo, MD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
*All identified conflicts of interest have been mitigated.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Call us at 877.CME.PROS (877.263.7767).
MMS-155-051425-89